DRDO COVID-19 drug to be Launched Next Week to Treat COVID-19 Patients
The first batch of 10,000 doses of 2-DG medicine for the treatment of Covid-19 infected patients would be launched early next week and will be given to patients," a DRDO official was quoted
The Defense Research and Development Organization officials announced on Friday that, the drug developed for treating COVID-19 patients will be launched in the next week. The first batch will have 10,000 doses of 2DG medicine.
The drug has been released by the extensive research team of DRDO lab Institute of Nuclear Medicine and Allied Sciences integrated with the high end professionals of Dr Reddy Laboratories.
"The first batch of 10,000 doses of 2-DG medicine for the treatment of Covid-19 infected patients would be launched early next week and will be given to patients," a DRDO official was quoted.
"The drug manufacturers are working on ramping up the production of the medicine for future use. The drug has been developed by a team of DRDO scientists including Dr Anant Narayan Bhatt," the official added.
The drug will be given as a therapy or an alternative treatment to the COVID-19 patients to assist the treatment. The drug will come in a powder form and can be taken by dissolving in water. This drug is more effective than the Standard of Care (SoC) with more efficacy shown at various end points.
